Desjardins A., Barboriak D., Herndon J.E., Reardon D., Quinn J., Rich J., Sathornsumetee S., Friedman H., Vredenburgh J. Evaluation of tumor response by dynamic contrast-enhanced magnetic resonance imaging in glioblastoma (gbm) patients treated with bevacizumab (bev) and irinotecan (CPT-11). Neuro-Oncology.
2007.
9
(4):
Journal Name : Neuro-Oncology Source : ISI
Desjardins A., Sathornsumetee S., Reardon D., Goli K., Bota D., Quinn J., Rich J., Gururangan S., Threatt S., Friedman A., Friedman H., Vredenburgh J. A phase I trial of the addition of the farnesyl transferase inhibitor SCH 66336 to temozolomide for patients with grade 3 or 4 malignant gliomas. Neuro-Oncology.
2007.
9
(4):
Journal Name : Neuro-Oncology Source : ISI
